Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent Chemotherapy

NCT01224405 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Advanced Prostate Cancer

Interventions

DRUG: Docetaxel + LH-RH analogues
DRUG: Docetaxel
DRUG: Docetaxel
DRUG: Continuous Docetaxel
DRUG: Continuous Docetaxel

Sponsor

University of Turin, Italy